Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04242095 · ClinicalTrials.gov registry record

Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects

A clinical trial of Malignancy, sponsored by Alliance for Clinical Trials in Oncology.

Recruiting
Registry status
240
Enrollment target
20
Study locations

NCT04242095 is a study of Malignancy that is actively recruiting participants, run by Alliance for Clinical Trials in Oncology. The registered enrollment target is 240 participants, below the 12,557-participant average among 8 other Malignancy trials with a reported enrollment target (98% lower). The trial reports 20 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04242095, a study of Malignancy, is actively recruiting participants, sponsored by Alliance for Clinical Trials in Oncology.

RECRUITING
Registry status
240 participants
Enrollment target
20
Study locations

Study Summary

This trial collects research data and samples from patients who experience immunotherapy side effects to store for use in future research studies. Studying research data and samples from patients who experience immunotherapy side effects may help researchers better understand how to predict, prevent, and treat these side effects.

Conditions Studied

Malignancy

Interventions

  • PROCEDURE Biospecimen Collection
  • OTHER Medical Chart Review

Study Locations (20)

Alaska

  • Anchorage Associates in Radiation Medicine - Anchorage
  • Anchorage Radiation Therapy Center - Anchorage
  • Alaska Breast Care and Surgery LLC - Anchorage
  • Alaska Oncology and Hematology LLC - Anchorage
  • Alaska Women's Cancer Care - Anchorage
  • Anchorage Oncology Centre - Anchorage
  • Katmai Oncology Group - Anchorage
  • Providence Alaska Medical Center - Anchorage
  • Fairbanks Memorial Hospital - Fairbanks

California

  • Mission Hope Medical Oncology - Arroyo Grande - Arroyo Grande
  • PCR Oncology - Arroyo Grande
  • Providence Saint Joseph Medical Center/Disney Family Cancer Center - Burbank
  • Mercy Cancer Center - Carmichael - Carmichael
  • Mercy San Juan Medical Center - Carmichael

Arizona

  • Kingman Regional Medical Center - Kingman
  • Cancer Center at Saint Joseph's - Phoenix
  • Mayo Clinic Hospital in Arizona - Phoenix

Arkansas

  • Mercy Hospital Fort Smith - Fort Smith
  • CHI Saint Vincent Cancer Center Hot Springs - Hot Springs
  • CARTI Cancer Center - Little Rock

Trial Details

FieldValue
Enrollment Target 240 participants
Start Date 2020-03-12
Est. Completion 2026-10-01

Sponsor

Alliance for Clinical Trials in Oncology

446 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04242095

The ClinicalTrials.gov registry entry for NCT04242095 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 240 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,557-participant average among 8 other Malignancy trials with a reported enrollment target (98% lower). The listed sponsor is Alliance for Clinical Trials in Oncology, which has 446 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Malignancy appearing as the primary indexed condition, and to 2 interventions - of which Biospecimen Collection is the first listed.

NCT04242095 reports 20 study locations spanning 4 distinct geographic areas - top geographies include Alaska, California, Arizona.

Frequently Asked Questions

What is clinical trial NCT04242095 about?

NCT04242095 is a clinical study titled "Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects". This trial collects research data and samples from patients who experience immunotherapy side effects to store for use in future research studies. Studying research data and samples from patients who experience immunotherapy side effects may help researchers better understand how to predict, prevent...

What is the current status of trial NCT04242095?

This trial is currently recruiting. The enrollment target is 240 participants. The study started on 2020-03-12. Estimated completion is 2026-10-01.

What conditions does trial NCT04242095 study?

This clinical trial studies the following conditions: Malignancy.

What interventions are being tested in trial NCT04242095?

The interventions under investigation include: Biospecimen Collection (PROCEDURE), Medical Chart Review (OTHER).

Who is sponsoring clinical trial NCT04242095?

This trial is sponsored by Alliance for Clinical Trials in Oncology, which has 446 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04242095 being conducted?

This trial has 20 study locations across Alaska, Arizona, Arkansas, California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Malignancy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Malignancy

All registered trials for this condition

Alaska

All trials with a study site in Alaska

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.